Iqvia Holdings, Inc. · NYSE:IQV
Iqvia — Q1 2021 Earnings Presentation
15 slides from Iqvia's earnings presentation, Apr 22, 2021
Slide 1: Q1 2021 Earnings Call
Q1 2021 Earnings Call April 22, 2021 © 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.
Slide 2: Legal: Safe Harbor Statement
Legal This presentation should be viewed in conjunction with IQVIA’s Q1 2021 earnings call Safe Harbor Statement for Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 19
Slide 3: Legal: Non-GAAP Information
Legal Non-GAAP Information This presentation includes information based on financial measures that are not recognized under generally accepted accounting principles in the United States (“GAAP”), such as Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted Earnings per Share. Non-GAAP financia
Slide 4: 1st Quarter Results
1st Quarter Results $M, except per share data Revenue Adjusted EBITDA(1) Adjusted Diluted EPS(1) 23.8% AFx 32.4% AFx 45.3% AFx 21.4% CFx $2.18 $3,409 $744 $2,754 $562 $1.50 Q1 2021 Q1 2020 Q1 2021 Q1 2020 Q1 2021 Q1 2020 Dollars are at actual foreign exchange rates. AFx is actual currency. CFx is co
Slide 5: 1st Quarter Revenue
1st Quarter Revenue $M 2021 2020 VPY% AFx VPY% CFx Technology & Analytics Solutions $1,348 $1,117 20.7% 17.1% Research & Development Solutions $1,868 $1,441 29.6% 28.1% Contract Sales & Medical Solutions $193 $196 (1.5)% (4.1)% Revenue $3,409 $2,754 23.8% 21.4% Dollars are at actual foreign exchange
Slide 6: 1st Quarter Profit
1st Quarter Profit $M, except per share data 2021 2020 Adjusted EBITDA (1) $744 $562 Net Income $212 $82 Diluted Earnings per Share $1.09 $0.42 Adjusted Net Income (1) $425 $294 Adjusted Diluted Earnings per $2.18 $1.50 Share (1) Dollars are at actual foreign exchange rates. (1) See reconciliations
Slide 7: R&D Solutions Backlog and NTM Revenue
R&D Solutions Backlog and NTM Revenue $B Backlog Next Twelve Months Revenue $23.2 $6.5 +18.3% +31.1% $19.6 $4.9 Q1 2020 Q1 2021 Q1 2020 Q1 2021 Dollars are at actual foreign exchange rates. NTM: Next Twelve Months 6
Slide 8: 1st Quarter Balance Sheet and Cash Flow Items and Metrics
1st Quarter Balance Sheet and Cash Flow Items and Metrics $M Cash & Cash Equivalents $2,305 Gross Debt $12,236 Net Debt $9,931 Gross Leverage Ratio (1) 4.8x Net Leverage Ratio (1) 3.9x Net Cash Provided by Operating Activities $867 Capital Expenditures $149 Free Cash Flow $718 Dollars are at actual
Slide 9: Full-Year 2021 Guidance
Full-Year 2021 Guidance $M, except per share data Updated Guidance Updated Guidance Guidance April 22 April 1(1) Feb 10(2) Revenue $13,200 - $13,500 $12,550 - $12,900 $12,550 - $12,900 VPY%(3) 16.2% - 18.8% 10.5% - 13.6% 10.5% - 13.6% Adjusted EBITDA $2,900 - $2,965 $2,760 - $2,840 $2,760 - $2,840 V
Slide 10: Q2 2021 Guidance
Q2 2021 Guidance $M, except per share data Guidance VPY%(1) Revenue $3,225 – $3,300 27.9% – 30.9% Adjusted EBITDA $690 – $715 42.9% – 48.0% Adjusted Diluted EPS $2.00 – $2.10 69.5% – 78.0% (1) Growth rates are at actual foreign currency exchange rates All financial guidance assumes current foreign c
Slide 11: Q&A
Q&A 10
Slide 12: Appendix
SSlIQVIA Appendix
Slide 13: Net Income to Adjusted EBITDA Reconciliation
Net Income to Adjusted EBITDA Reconciliation $M 12
Slide 14: Net Income to Adj. Net Income and Per Share Data Reconciliation
Net Income to Adj. Net Income and Per Share Data Reconciliation $M, except per share data (1) Reflects all the amortization of acquired intangible assets. 13 (2) Reflects the portion of Q2 Solutions' after-tax non-GAAP adjustments attributable to the minority interest partner.
Slide 15: Leverage Ratios
Leverage Ratios $M Gross Debt, net of Original Issue Discount, as of March 31, 2021 $ 12,236 Net Debt as of March 31, 2021 $ 9,931 Adjusted EBITDA for the twelve months ended March 31, 2021 $ 2,566 Gross Leverage Ratio (Gross Debt/LTM Adjusted EBITDA) 4.8x Net Leverage Ratio (Net Debt/LTM Adjusted E